We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





72nd AACC Annual Scientific Meeting & Clinical Lab Expo Rescheduled to December 13-17, 2020 Due to COVID-19

By LabMedica International staff writers
Posted on 17 Apr 2020
Print article
Illustration
Illustration
In view of the ongoing spread of COVID-19 across the world and its growing global impact, the American Association for Clinical Chemistry {(AACC) Washington, DC, USA} has decided to reschedule the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo to December in order to ensure a healthy and safe meeting experience for all attendees. The AACC Clinical Lab Expo was originally scheduled to be held July 26-30, 2020 in Chicago, IL, USA.

AACC is a global scientific and medical professional organization dedicated to clinical laboratory science and its application to healthcare. AACC helps lab professionals adapt to change and provides vital insight and guidance so patients get the care they need. With more than 800 companies exhibiting, the AACC Clinical Lab Expo is the world’s largest exposition for clinical laboratory products and services.

AACC’s leadership has been carefully monitoring the COVID-19 outbreak and consulting members, staff, industry, and other experts. Based on input from all stakeholder groups, and in close collaboration with host city officials, the AACC has announced that it will be able to preserve the complete Annual Scientific Meeting & Clinical Lab Expo experience to which its members, exhibitors, and the entire laboratory medicine community have been looking forward.

The 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will now be held December 13 – 17, 2020 at McCormick Place in Chicago, IL, USA. Rescheduling the event will enable AACC to provide the experience that its attendees and exhibitors expect. The AACC has reaffirmed that the association remains committed to supporting the essential work of laboratory medicine professionals and to holding an event that unites and strengthens the industry in the face of enormous challenges.

Related Links:
American Association for Clinical Chemistry (AACC)

Gold Member
Multiplex Genetic Analyzer
MassARRAY Dx Analyzer (Europe only)
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Mumps Virus Test
ZEUS ELISA Mumps IgG Test System

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.